Press Releases on May 14, 2025 - EIN Presswire - Press Release Distribution Service

Published on May 14, 2025 - 20:01 GMT

Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease; Initial Data Expected in Q1 2026 MZE782 Phase 1 Healthy Volunteer Trial Ongoing; Initial Data Expected in Q3 2025 Strong Balance Sheet with $294.4 Million in Cash and Cash …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 14, 2025 - 20:01 GMT

Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference

VANCOUVER, British Columbia and BOSTON, May 14, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on May 14, 2025 - 20:01 GMT

Capital Southwest Announces Financial Results for Fourth Fiscal Quarter and Fiscal Year Ended March 31, 2025

DALLAS, May 14, 2025 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest,” “CSWC” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the …

Distribution channels: Business & Economy ...

Published on May 14, 2025 - 20:01 GMT

Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress

SAN DIEGO, May 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the first quarter ended March 31, 2025. “The first quarter of 2025 represents the first full quarter of execution after shifting strategy …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 14, 2025 - 20:01 GMT

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

On track to report topline results from Phase 2 BESTOW trial in kidney transplantation in fourth quarter of 2025 Tegoprubart used as a key component of immunosuppression regimen in its second transplant of a genetically modified pig kidney into a human …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 14, 2025 - 20:01 GMT

Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update

The primary completion date of the PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is expected in June 2025 and a topline data readout is anticipated in the third quarter of 2025 Enrollment is ongoing in the PIK3CA mutant cohort of the VIKTORIA-1 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on May 14, 2025 - 20:01 GMT

Conifer Holdings Reports 2025 First Quarter Financial Results

TROY, Mich., May 14, 2025 (GLOBE NEWSWIRE) -- Conifer Holdings, Inc. (Nasdaq: CNFR) (“Conifer” or the “Company”) today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights Personal Lines production was up …

Distribution channels: Business & Economy, Insurance Industry ...

Published on May 14, 2025 - 20:01 GMT

Monogram Technologies Reports First Quarter 2025 Financial Results

Receives FDA Clearance for the mBôs™ TKA System Groundbreaking Trial Set to Deliver one of the World’s First Autonomous Saw-Based Robotic TKA Surgeries on Live Patients Management to Host Business Update Conference Call Today at 4:30 p.m. Eastern Time …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...